NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

To establish a more appropriate animal recipient for xenotransplantation, NOD/SCID/gamma(c)(null) mice double homozygous for the severe combined immunodeficiency (SCID) mutation and interleukin-2Rgamma (IL-2Rgamma) allelic mutation (gamma(c)(null)) were generated by 8 backcross matings of C57BL/6J-gamma(c)(null) mice and NOD/Shi-scid mice. When human CD34+ cells from umbilical cord blood were transplanted into this strain, the engraftment rate in the peripheral circulation, spleen, and bone marrow were significantly higher than that in NOD/Shi-scid mice treated with anti-asialo GM1 antibody or in the beta2-microglobulin-deficient NOD/LtSz-scid (NOD/SCID/beta2m(null)) mice, which were as completely defective in NK cell activity as NOD/SCID/gamma(c)(null) mice. The same high engraftment rate of human mature cells was observed in ascites when peripheral blood mononuclear cells were intraperitoneally transferred. In addition to the high engraftment rate, multilineage cell differentiation was also observed. Further, even 1 x 10(2) CD34+ cells could grow and differentiate in this strain. These results suggest that NOD/SCID/gamma(c)(null) mice were superior animal recipients for xenotransplantation and were especially valuable for human stem cell assay. To elucidate the mechanisms involved in the superior engraftment rate in NOD/SCID/gamma(c)(null) mice, cytokine production of spleen cells stimulated with Listeria monocytogenes antigens was compared among these 3 strains of mice. The interferon-gamma production from dendritic cells from the NOD/SCID/gamma(c)(null) mouse spleen was significantly suppressed in comparison with findings in 2 other strains of mice. It is suggested that multiple immunological dysfunctions, including cytokine production capability, in addition to functional incompetence of T, B, and NK cells, may lead to the high engraftment levels of xenograft in NOD/SCID/gamma(c)(null) mice.

[1]  S. Asano,et al.  Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice , 2000, Bone Marrow Transplantation.

[2]  H. Ben‐Hur,et al.  β2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function , 2000 .

[3]  Mamoru Ito,et al.  Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. , 2000, The Journal of clinical investigation.

[4]  Mamoru Ito,et al.  Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. , 1999 .

[5]  J. D. Di Santo,et al.  Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain , 1998 .

[6]  C. Eaves,et al.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Roopenian,et al.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. , 1997, Journal of immunology.

[8]  Y. Ueyama,et al.  High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. , 1997, Leukemia.

[9]  Jianfei Yang,et al.  Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes , 1997, Infection and immunity.

[10]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[11]  G. Beamer,et al.  Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. , 1996, Cellular immunology.

[12]  M. Katsuki,et al.  Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. , 1996, Blood.

[13]  E. Leiter,et al.  Emv30null NOD-scid Mice: An Improved Host for Adoptive Transfer of Autoimmune Diabetes and Growth of Human Lymphohematopoietic Cells , 1995, Diabetes.

[14]  J. Cheverud,et al.  Polymorphism for PCR-analyzed microsatellites between the inbred mouse strains LG and SM , 1995, Mammalian Genome.

[15]  D. Greiner,et al.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. , 1995, The American journal of pathology.

[16]  K. Yasukawa,et al.  gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Greiner,et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.

[18]  I. Bernstein,et al.  Strain-dependent leakiness of mice with severe combined immune deficiency. , 1993, Journal of immunology.

[19]  B. Croy,et al.  Engraftment of severe combined immune deficient/beige mice with bovine foetal lymphoid tissues. , 1992, Veterinary immunology and immunopathology.

[20]  R. Steinman,et al.  Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes , 1992, The Journal of experimental medicine.

[21]  D E Mosier,et al.  Human immunodeficiency virus infection of human-PBL-SCID mice. , 1991, Science.

[22]  T. Hongyo,et al.  SCID (severe combined immunodeficiency) mice as a new system to investigate metastasis of human tumors. , 1990, Journal of radiation research.

[23]  I. Weissman,et al.  Infection of the SCID-hu mouse by HIV-1. , 1988, Science.

[24]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[25]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[26]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[27]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[28]  H. Ben‐Hur,et al.  beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. , 2000, Blood.

[29]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.